BLEEDING NEWS'21

Noviembre, Número 80

  • First-Line Administration of Fibrinogen Concentrate in the Bleeding Trauma Patient: Searching for Effective Dosages and Optimal Post-Treatment Levels Limiting Massive Transfusion-Further Results of the RETIC Study.

  • Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial.

  • Dynamics of Platelet Counts in Major Trauma: The Impact of Haemostatic Resuscitation and Effects of Platelet Transfusion-A Sub-Study of the Randomized Controlled RETIC Trial.

Octubre, Monográfico III. Número 79

  • Monográfico III: Anticoagulación y riesgo de sangrado en la terapia de oxigenación extracorpórea.

Septiembre, Número 78

  • Fibrinógeno en la reanimación inicial de trauma severo (FiiRST): un ensayo de viabilidad aleatorio

  • Evaluación de la coagulopatía inducida por trauma en el fibrinógeno en la reanimación inicial del ensayo de trauma severo

  • Algoritmo de tratamiento simplificado para el manejo de la hemorragia inducida por trauma sin pruebas viscoelásticas
     

Julio, Número 77

  • A meta-analysis of andexanet alfa and prothrombin complex concentrate in the treatment of factor Xa inhibitor-related major bleeding

  • Prothrombin complex concentrate in major bleeding associated with DOACs; an updated systematic review and meta-analysis

  • Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products

Junio, Monográfico II. NATA

  • Session 1A: SAFETY OF BLOOD AND BLOOD PRODUCTS

  • Session 2A: HOT TOPICS I-CLINICAL TRANSFUSION PRACTICE

  • Session 5A: CELL SALVAGE-OUTDATED OR UP TO DATE?

  • Session 10A: PATIENT BLOOD MANAGEMENT IN THE ICU

  • Session 11A: HOT TOPICS IV: BLEEDING AND THROMBOSIS

  • SIMPOSIUM CSL BEHRING: THE ROLE OF FACTOR CONCENTRATES IN BLEEDING COAGULOPATHY
     

Mayo, Número 75

  • Altered Fibrinolysis during and after Surgery

  • The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease

  • Role of fibrinogen concentrates for treatment of critical perioperative hemorrhage

Abril, Monográfico I. Número 74

  • Monográfico COVID-19. Especial Bleeding news

Marzo, Número 73

  • Patient blood management interventions do not lead to important clinical benefits or cost-effectiveness for major surgery: a network meta-analysis

  • Red blood cell transfusion in obstetrics and its implication for patient blood management: a retrospective analysis in Switzerland from 1998 to 2016

  • Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference

Febrero, Número 72

  • Variations and obstacles in the use of coagulation factor concentrates for major trauma bleeding across Europe: outcomes from a European expert meeting

  • Institution of prothrombin complex concentrate protocols is associated with a reduction in plasma administration at a Tertiary Care Hospital

  • Whole Blood, Fixed Ratio, or Goal-Directed Blood Component Therapy for the Initial Resuscitation of Severely Hemorrhaging Trauma Patients: A Narrative Review

​​

coronavirus.jpg
NATA.JPG